Search by Drug Name or NDC
NDC 76329-3318-01 Epinephrine 0.1 mg/mL Details
Epinephrine 0.1 mg/mL
Epinephrine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by International Medication Systems, Limited. The primary component is EPINEPHRINE.
MedlinePlus Drug Summary
Epinephrine injection is used along with emergency medical treatment to treat life-threatening allergic reactions caused by insect bites or stings, foods, medications, latex, and other causes. Epinephrine injection is also used to treat life-threatening low blood pressure associated with septic shock (a serious condition caused by a body-wide infection that can lead to dangerously low blood pressure and organ failure) in hospitalized adults. Epinephrine is in a class of medications called alpha- and beta-adrenergic agonists (sympathomimetic agents). It works by relaxing the muscles in the airways and tightening the blood vessels.
Related Packages: 76329-3318-01Last Updated: 05/26/2024
MedLinePlus Full Drug Details: Epinephrine Injection
Product Information
| NDC | 76329-3318 |
|---|---|
| Product ID | 76329-3318_60d11fad-22ff-4b96-9d0c-ec94dbd586d6 |
| Associated GPIs | |
| GCN Sequence Number | 004934 |
| GCN Sequence Number Description | epinephrine SYRINGE 0.1 MG/ML INJECTION |
| HIC3 | J5A |
| HIC3 Description | ADRENERGIC AGENTS,CATECHOLAMINES |
| GCN | 19411 |
| HICL Sequence Number | 002050 |
| HICL Sequence Number Description | EPINEPHRINE |
| Brand/Generic | Generic |
| Proprietary Name | Epinephrine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Epinephrine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.1 |
| Active Ingredient Units | mg/mL |
| Substance Name | EPINEPHRINE |
| Labeler Name | International Medication Systems, Limited |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA211363 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 76329-3318-01 (76329331801)
| NDC Package Code | 76329-3318-1 |
|---|---|
| Billing NDC | 76329331801 |
| Package | 10 CARTON in 1 PACKAGE (76329-3318-1) / 1 SYRINGE in 1 CARTON / 10 mL in 1 SYRINGE |
| Marketing Start Date | 2023-01-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |